ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The British DNA sequencer company Oxford Nanopore Technologies has raised $140 million from a group of investors. The company sells the MinION, a popular handheld gene sequencer that can be plugged into a laptop to read DNA sequences in remote locations, including aboard the International Space Station. Oxford Nanopore is also introducing a larger, more powerful sequencer called the PromethION, and a small, real-time DNA sequencer called the Flongle that could be used to monitor infectious diseases. The company will use the funds to build a production facility for its sequencers at a U.K. science and business park.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X